Investigational Site Number : 1560011
Nanjing 210029
0 studies enrolling now · 1 studies all time
What they study most
Breast Cancer Metastatic
Studies at this site
Phase 2 Study of Amcenestrant (SAR439859) Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer
— Stopped early